Bioxyne (ASX:BXN) has signed a joint venture with Canxchange.
The partnership aims to launch an AI-powered B2B platform in Australia.
This upcoming platform, which is expected to go live in the fourth quarter of 2023, will target the rapidly expanding medicinal cannabis market in Australia.
Bioxyne is a biotechnological company involved in the development and commercialization of probiotic products.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
